AI and early digital twin models can help forecast trial performance, refine site feasibility, and anticipate operational needs before enrollment begins.
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- What Will Life Science Orgs Do When The AI Bill Comes Through?
- Clinical Trial Standards — What They Are And Why They're Indispensable
- The Data Was Already There: RWE's Real Bottleneck Is People
ON-DEMAND WEBINARS
How can wearable DHTs be leveraged to measure physical activity in patients with immunological diseases, enhancing clinical trials and advancing drug development?
Join the Co-CEO of CRIO, as he explores research site challenges and how site-based technologies can reduce administrative burdens, enhance efficiency, and eliminate redundant one-time-use technologies.
Whether you're a sponsor, site, or technology vendor, now is the time to embrace One Home and join this industry-wide collaboration.
Drug development in neurology is notoriously challenging. Despite being one of the most active areas of clinical development, neurological disease drug trials have among the longest development timelines and highest failure rates in the industry. In this webinar, learn how digital clinical measures enabled by wearables have great potential to transform and accelerate drug development in neuroscience.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1133924836 software]( "How SaaS Unlocks New Possibilities For Life Science Organizations")
How SaaS Unlocks New Possibilities For Life Science OrganizationsThe rise of SaaS (software-as-a-service) has transformed industries, including life sciences, by enabling new possibilities. See how it’s already helping life science organizations around the world today.
-
![GettyImages- 1180547354 trial data]( "No More Back And Forth: Building eCOAs Right The First Time")
No More Back And Forth: Building eCOAs Right The First TimeClinical trial system builds have long been plagued by inefficiencies, miscommunications, and long timelines. Learn about a platform helping sponsors and CRO's overcome these challenges.
-
![The US Biosimilar Approval Pathway: Policy Precedes Science - A Regulatory Perspective]( "Why Legacy RTSM Systems Create Risk in Biosimilar Trials")
Why Legacy RTSM Systems Create Risk in Biosimilar TrialsLearn how real-time visibility, adaptive supply planning, and proactive risk management can reduce waste and improve study execution.
-
![GettyImages-1356381571 world data]( "Using RWE To Get To Insights And Action — Faster")
Using RWE To Get To Insights And Action — FasterDelve into three examples that vividly showcase the formidable power of real-world evidence from the early stages of drug development through clinical trials and commercialization.
-
![GettyImages-2167387195-computer-graphs-hand-team-digital]( "Improving Clinical Trial Performance Through Central eSource")
Improving Clinical Trial Performance Through Central eSourceSee how a top five pharmaceutical company leveraged our esource platform to enhance site performance, improve data consistency, and enable remote monitoring.
-
![regulatory]( "Inova Health System Uses Advarra eReg Workflows And Integrations To Improve Regulatory Efficiency")
Inova Health System Uses Advarra eReg Workflows And Integrations To Improve Regulatory EfficiencyMaintaining efficient, effective regulatory management processes can be a significant challenge. At Inova Health System, the research team improved regulatory efficiency by 20% without the need for extra regulatory staff by adopting Advarra’s eRegulatory Management System.
-
![GettyImages-509115133 budget]( "Mastering Clinical Trial Forecasting Through Continuous Learning")
Mastering Clinical Trial Forecasting Through Continuous LearningStop treating trial budgets as fixed predictions. Discover how top teams refine financial forecasts by tracking shifting assumptions to improve governance and build trust.
-
![GettyImages-2153964833 data]( "What's Driving Data Innovation: Notes From The Front Lines Of Change")
What's Driving Data Innovation: Notes From The Front Lines Of ChangeClinical data innovators prioritize risk-based quality management, standards, and closer collaboration with research sites. Many see AI as an important support rather than a top priority.
-
![High speed hi-tech technology-GettyImages-2158132091]( "Reflections From ISOQOL Conference 2024")
Reflections From ISOQOL Conference 2024Greta van Schoor attended the 31st Annual ISOQOL Conference, where HRQOL leaders shared insights on optimizing eCOA collection, integrating PROs, and digital health in clinical research.
-
![GettyImages- 1180547354 trial data]( "Simplifying The Data Journey From EHR To EDC")
Simplifying The Data Journey From EHR To EDCExplore how open API architecture represents a significant advancement in the integration of EHR and EDC systems, enhancing the potential of EHR data for clinical research.
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
RECENT NEWSLETTERS
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
